1-3 of 3
Yuji Matsumoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations

Hitomi Jo, Shigehiro Yagishita, Yoshiharu Hayashi, Shoraku Ryu, Mikiko Suzuki, Shinji Kohsaka, Toshihide Ueno, Yuji Matsumoto, Hidehito Horinouchi, Yuichiro Ohe, Shun-ichi Watanabe, Noriko Motoi, Yasushi Yatabe, Hiroyuki Mano, Kazuhisa Takahashi, Akinobu Hamada
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (2): 359–370.
https://doi.org/10.1158/1535-7163.MCT-21-0371
Published: 08 February 2022
View article titled, Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations
Open the PDF for Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations in another window
Includes: Supplementary data
Journal Articles

Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways

Yusuke Tomita, Kazuhiko Kurozumi, Ji Young Yoo, Kentaro Fujii, Tomotsugu Ichikawa, Yuji Matsumoto, Atsuhito Uneda, Yasuhiko Hattori, Toshihiko Shimizu, Yoshihiro Otani, Tetsuo Oka, Balveen Kaur, Isao Date
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (8): 1418–1429.
https://doi.org/10.1158/1535-7163.MCT-18-0799
Published: 01 August 2019
View article titled, Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways
Open the PDF for Oncolytic Herpes Virus Armed with Vasculostatin in Combination with Bevacizumab Abrogates Glioma Invasion via the CCN1 and AKT Signaling Pathways in another window
Includes: Supplementary data
Journal Articles

δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion

Toshihiko Shimizu, Joji Ishida, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Yoshihiro Otani, Tetsuo Oka, Yusuke Tomita, Yasuhiko Hattori, Atsuhito Uneda, Yuji Matsumoto, Isao Date
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (4): 812–822.
https://doi.org/10.1158/1535-7163.MCT-18-0138
Published: 01 April 2019
View article titled, δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion
Open the PDF for δ-Catenin Promotes Bevacizumab-Induced Glioma Invasion in another window
Includes: Supplementary data